homocystine has been researched along with Anterior Choroidal Artery Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, MJ; Dippel, DW; Koudstaal, PJ; van Goor, ML | 1 |
| Kitamura, K; Kurihara, H; Morita, H; Sugiyama, T; Sumiyoshi, T; Suzuki, S; Yazaki, Y | 1 |
| Chambless, LE; Howard, VJ; Malinow, MR; Pettigrew, LC; Spence, JD; Stampfer, M; Toole, JF | 1 |
1 trial(s) available for homocystine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design.
Topics: Adult; Aged; Cerebral Infarction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Homocysteine; Homocystine; Humans; Male; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
2 other study(ies) available for homocystine and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA.
Topics: Adolescent; Adult; Cerebral Infarction; Disease-Free Survival; Female; Follow-Up Studies; Homocystine; Humans; Ischemic Attack, Transient; Male; Recurrence; Retrospective Studies; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2005 |
[Genetic polymorphisms of methylenetetrahydrofolate reductase and methionine synthase: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Alleles; Asian People; Cerebral Infarction; Coronary Disease; Homocystine; Humans; Japan; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 1999 |